Jiangsu (SH:688426) Shang Hai Zheng Quan Bao·2026-01-14 18:14Core Viewpoint - Jiangsu Kangwei Century Biotechnology Co., Ltd. announced a share reduction plan involving some directors and senior management due to personal financial needs related to tax obligations from the stock option incentive plan [3][10]. Summary by Sections Shareholding Information - As of the announcement date, key personnel hold the following shares: - Ms. Zhuang Zhihua: 208,930 shares (0.1857% of total shares), with 121,098 shares held indirectly through an employee stock ownership platform [2]. - Mr. Qi Yubai: 163,872 shares (0.1457% of total shares), with 118,625 shares held indirectly [2]. - Mr. Yin Jianfeng: 116,818 shares (0.1038% of total shares), with 76,894 shares held indirectly [2]. Reduction Plan Details - The reduction plan includes: - Ms. Zhuang Zhihua: up to 21,958 shares (0.0195% of total shares) - Mr. Qi Yubai: up to 11,311 shares (0.0101% of total shares) - Mr. Yin Jianfeng: up to 9,981 shares (0.0089% of total shares) - The reduction period is set for three months starting 15 trading days after the announcement [3][6]. Background on Shareholding - The mentioned directors and senior management have not reduced their holdings since the company went public on October 25, 2022 [5]. Compliance and Commitments - The reduction plan aligns with previous commitments made under the 2021 stock option incentive plan, which restricts the transfer of shares for 36 months post-exercise [8][9]. - The company confirms that the reduction does not violate any regulations regarding shareholding reductions [11].